These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27932109)

  • 1. Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.
    Brakemeier S; Dürr M; Bachmann F; Schmidt D; Gaedeke J; Budde K
    Transplant Proc; 2016 Nov; 48(9):2924-2930. PubMed ID: 27932109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for Pneumocystis jirovecii pneumonia after kidney transplantation: A systematic review and meta-analysis.
    Cheng B; Qi C; Zhang S; Wang X
    Clin Transplant; 2024 May; 38(5):e15320. PubMed ID: 38690617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
    Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
    Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.
    Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D
    BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P; Zhu X; Liang W; Cai R
    Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients.
    Lee SH; Huh KH; Joo DJ; Kim MS; Kim SI; Lee J; Park MS; Kim YS; Kim SK; Chang J; Kim YS; Kim SY
    Sci Rep; 2017 May; 7(1):1571. PubMed ID: 28484270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
    Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
    Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.
    Yetmar ZA; Duffy D; Smith BH; Vikram HR; Brumble L; Limper AH; Beam E
    Clin Transplant; 2023 Sep; 37(9):e15021. PubMed ID: 37195184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and risk factors for late-onset pneumocystis jirovecii pneumonia in kidney transplantation recipients.
    Zhu X; Xie M; Fan J; Geng B; Fei G; Zhou Q; Wu H; Liu X; Jiang X
    Mycoses; 2024 Jan; 67(1):e13688. PubMed ID: 38214337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study.
    Lee G; Koo TY; Kim HW; Lee DR; Lee DW; Oh J; Kim BS; Kim MS; Yang J;
    Sci Rep; 2022 Jun; 12(1):10682. PubMed ID: 35739203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.
    Sarwar S; Carey B; Hegarty JE; McCormick PA
    Transpl Infect Dis; 2013 Oct; 15(5):510-5. PubMed ID: 23930824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial Pneumocystis jirovecii pneumonia: lessons from a cluster in kidney transplant recipients.
    Phipps LM; Chen SC; Kable K; Halliday CL; Firacative C; Meyer W; Wong G; Nankivell BJ
    Transplantation; 2011 Dec; 92(12):1327-34. PubMed ID: 22129760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case-control study.
    Tadros S; Teichtahl AJ; Ciciriello S; Wicks IP
    Semin Arthritis Rheum; 2017 Jun; 46(6):804-809. PubMed ID: 27814896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia.
    Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW
    Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
    Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept.
    Haidinger M; Hecking M; Memarsadeghi M; Weichhart T; Werzowa J; Hörl WH; Säemann MD
    Transpl Infect Dis; 2009 Apr; 11(2):171-4. PubMed ID: 19210692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical descriptive analysis of severe
    Xie D; Xu W; You J; Yuan X; Li M; Bi X; Zhang K; Li H; Xian Y
    Bioengineered; 2021 Dec; 12(1):1264-1272. PubMed ID: 33896387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.